Clinical Trial Update: Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 BEACON trial is evaluating a new PSMA imaging agent versus MRI for detecting prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Carcinoma | EARLY_Phase 1 | Status: RECRUITING